Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia.
published in: Cancer
date of publication: 2007-03-01
language: English
main subject: chronic myeloid leukemia, leukemia, imatinib
Cites articles 25
- 1999-02
Date
Title
Article - wd:Q40459776